Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid peroxyl radicals (LOO•) and reactive oxygen species (ROS) within biological membranes are critical intermediates that drive the oxidative degradation of polyunsaturated fatty acids (PUFAs), a process known as lipid peroxidation (Ayala et al., 2014, Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal). These species are generated during a self-propagating radical chain reaction that, if not neutralized by endogenous antioxidants like Glutathione Peroxidase 4 (GPX4), leads to extensive membrane damage and cellular dysfunction. The accumulation of these membrane-localized radicals is the defining feature of ferroptosis, an iron-dependent form of regulated cell death implicated in various pathologies including neurodegeneration and ischemia (Dixon et al., 2012, Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death). Therapeutic intervention typically involves the administration of lipophilic radical-trapping antioxidants (RTAs) or chain-breaking antioxidants, such as Vitamin E or synthetic inhibitors like ferrostatin-1, which intercept peroxyl radicals and prevent the destruction of the lipid bilayer (Conrad et al., 2018, Regulation of Lipid Peroxidation and Ferroptosis in Diverse Species). Targeting these reactive species is a major focus in developing treatments for stroke, myocardial infarction, and neurodegenerative disorders where oxidative membrane damage is a primary driver of tissue loss.
Chain-breaking antioxidant activity through the scavenging of lipid peroxyl radicals to terminate the lipid peroxidation cascade.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid peroxyl radicals and reactive oxygen species in membranes (LOO•/ROS).